A Multicenter Study of Docetaxel at a Dose of 100 mg/m(2) in Japanese Patients with Advanced or Recurrent Breast Cancer

OBJECTIVE: This study examined the pharmacokinetics, safety and anti-tumor activity of docetaxel at a dose of 100 mg/m(2) in Japanese patients with advanced or recurrent breast cancer. METHODS: Japanese patients with advanced or recurrent breast cancer received docetaxel at a dose of 100 mg/m(2) int...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirata, Taizo, Ozaki, Shinji, Tabata, Masahiro, Iwamoto, Takayuki, Hinotsu, Shiro, Hamada, Akinobu, Motoki, Takayuki, Nogami, Tomohiro, Shien, Tadahiko, Taira, Naruto, Matsuoka, Junji, Doihara, Hiroyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112988/
https://www.ncbi.nlm.nih.gov/pubmed/33191320
http://dx.doi.org/10.2169/internalmedicine.5089-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112988/
https://www.ncbi.nlm.nih.gov/pubmed/33191320
http://dx.doi.org/10.2169/internalmedicine.5089-20

Ejemplares similares